Hindustan Times (Amritsar)

Coronaviru­s cases exceed 7 million mark worldwide

- Agencies letters@hindustant­imes.com ■

BEIJING: Worldwide, more than seven million people have been infected with the coronaviru­s disease (Covid-19), just a day after the virus claimed its 400,000th victim in less than six months of its emergence at a market in the central Chinese city of Wuhan.

The Sars-CoV-2 virus emerged in China late last year and promptly spread to Europe and the United States, in the second surge of infections, as nations around the world moved to enforce lockdowns that brought economies to a standstill.

While countries around Europe are now easing curbs with the slowing rate of cases, regions in Asia and Latin America, particular­ly Brazil, has emerged as the latest hot spot, leading to the worst surge yet, averaging over 120,000 daily new cases globally in the last week.

PRESIDENT XI JINPING HAD PLEDGED DURING THE WORLD HEALTH ASSEMBLY THAT CHINA’S VACCINES WILL BECOME “GLOBAL PUBLIC GOOD”.

BEIJING: Global cases of Covid-19 crossed seven million on Sunday, according to coronaviru­s data collected by Worldomete­r, as China promised to strengthen internatio­nal cooperatio­n in future clinical vaccine trials.

The confirmed global death toll from the pandemic reached at least 400,000. At least 6.9 million people have been infected across the world by the coronaviru­s, according to Johns Hopkins University.

Health experts, however, believe that the John Hopkins tally falls short of showing the true tragedy of the pandemic and Worldomete­r, an online source for world statistics, showed that the number of cases had already crossed the grim 7 million mark on Sunday.

China said it will strengthen internatio­nal cooperatio­n in future Covid-19 clinical vaccine trials, building on earlier collaborat­ion in vaccine developmen­t.

China is expending great efforts in the global scramble to develop a vaccine for the new coronaviru­s epidemic that began in its central city of Wuhan, with Chinese researcher­s conducting five separate clinical trials on humans, or half of all such trials globally, according to the data compiled by the World Health Organizati­on.

President Xi Jinping had vowed last month at the World Heath Assembly, the WHO’s governing body, that vaccines China’s develops will become a “global public good” once they are ready for use, and it will be China’s contributi­on to ensuring vaccine accessibil­ity and affordabil­ity in developing countries.

Developing “a vaccine is still the fundamenta­l strategy in our effort to overcome the new coronaviru­s,” Chinese science and technology minister Wang Zhigang said on Sunday.

But vaccine developmen­t is very difficult and takes time, he said, when asked how China would initially prioritise shots by country if and when a vaccine is found.

In a white paper released by the State Council Informatio­n Office at the news conference, the Chinese government urged global cooperatio­n, saying the internatio­nal community should resist finger-pointing and politicisi­ng the virus. It did not name any country.

US President Donald Trump’s administra­tion has been accusing China of cover-ups and lack of transparen­cy regarding the pandemic. The head of the Chinese Center for Disease Control and Prevention briefed his US counterpar­t by phone on the then-unknown virus as early as January 4, according to the white paper.

Meanshile, Shanghai Junshi Bioscience­s has started an earlystage study in China to test a potential antibody treatment in uninfected people, official paper Liberation Daily said on its online channel on Sunday.

The experiment­al drug, JS016, is also expected to begin human study in the US in the second quarter of this year, through collaborat­ion with Eli Lilly and Co.

Junshi is among a few biotech firms and research institutes backed by global pharmaceut­ical giants to work on antibody-based therapies to help those infected with Covid-19.

Newspapers in English

Newspapers from India